Yes. The U.S. Food and Drug Administration (FDA) approved Syfovre as a treatment for geographic atrophy in February 2023.
However, serious side effects of Syfovre have been recorded since the drug became available to the public.
Fill out our contact form now if you were injured after receiving a Syfovre injection. We can help you determine your legal options during a free case review.